2019
DOI: 10.1016/j.resp.2019.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Amelioration of allergic asthma by Ziziphora clinopodioides via upregulation of aquaporins and downregulation of IL4 and IL5

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 62 publications
2
4
0
Order By: Relevance
“…IL-4’s inhibitory effects are also extended to the osteoclasts, which play a critical role in cartilage destruction and bone erosion. Recombinant IL-4 therapy has shown promising results in RA patients by suppressing cytokine production and inflammatory processes . In our study, Ct significantly augmented the expression of IL-4 in all of the treatment groups.…”
Section: Discussionsupporting
confidence: 59%
“…IL-4’s inhibitory effects are also extended to the osteoclasts, which play a critical role in cartilage destruction and bone erosion. Recombinant IL-4 therapy has shown promising results in RA patients by suppressing cytokine production and inflammatory processes . In our study, Ct significantly augmented the expression of IL-4 in all of the treatment groups.…”
Section: Discussionsupporting
confidence: 59%
“…Moreover, it is responsible for negative regulation of NF- κ B by increasing I κ B. IL-4 inhibits osteoclasts which are responsible for the destruction of cartilage and bone erosion in arthritic patients. Recombinant IL-4 therapy has resulted in the inhibition of cytokine production in patients suffering from RA [ 44 ]. J. regia significantly increased the levels of IL-4 in the treatment groups when compared to the positive arthritis control group.…”
Section: Discussionmentioning
confidence: 99%
“…These alterations of transcriptomes may have mediated the mechanisms underlying the correlation between AQP1 methylation and the prognosis of elderly CN-AML. While there are no novel drugs targeting AQP1 DNA methylation-related genes, there are demethylation drugs such as DNA methyltransferase inhibitors [5-azacytidine (52) and 5-aza-2 ′ -deoxycytidine (53)], second-generation DNMT inhibitors [Zebularine (54) and Guadecitabine (55)], and lysine demethylase inhibitors (56), and drugs that affect the expression level of AQP1 like Ziziphora clinopodioides which upregulates aquaporin 1 (57). It is worth noting that drugs affecting AQP1 expression are not currently used for cancer treatment.…”
Section: Discussionmentioning
confidence: 99%